Ginkgo Bioworks Wins Up to $47 Million Contract to Build Automated Phenotyping Platform for PNNL
Reuters
Dec 05
Ginkgo Bioworks Wins Up to $47 Million Contract to Build Automated Phenotyping Platform for PNNL
Ginkgo Bioworks Holdings Inc. announced it has been awarded a four-year contract worth up to $47 million by the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory. Under the agreement, Ginkgo will co-design, build, and integrate a High-Throughput Automated Phenotyping Platform to support the Department of Energy's Microbial Molecular Phenotyping Capability. The platform aims to enable large-scale, reproducible microbial and microbiome data generation and will utilize Ginkgo Automation's Catalyst scheduling software and modular Reconfigurable Automation Carts. The initiative is intended to enhance phenotyping throughput, support AI/ML applications, and provide a scalable foundation for future research instrumentation and workflows.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE40114) on December 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.